EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Longitudinal deterioration of subjective cognitive decline in apolipoprotein ε4 carriers and improvement of subjective cognitive decline by multi-domain intervention for prevention of dementia: The cognitive function instrument assessment

Tohmi Osaki iD, Yutaro Oki iD, Ryoko Kumagai iD, Rei Ono, Hisafumi Yasuda, Yoji Nagai, Hisatomo Kowa

Journal of Alzheimer’s Disease · 2025

DOI: 10.1177/13872877251332647 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Alzheimer’s Disease, 2025. Verfasst von Tohmi Osaki und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Occupational Therapy, Faculty of Rehabilitation, Kobe Gakuin University, Ikawadani-cho, Nishi-ku, Kobe, Japan. Hauptthemen laut MEDLINE: Apolipoprotein E4, Cognitive Dysfunction, Dementia. Die Arbeit nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Subjective cognitive decline represents an early stage of mild cognitive impairment, with the Cognitive Function Instrument (CFI) serving to subjectively evaluate the decline in daily living activities associated with this minor cognitive decline.

Objective

To examine how CFI scores change with apolipoprotein E ε4 (ApoE4) carriage, objective cognitive decline, and dementia prevention intervention. We aimed to assess CFI's usefulness in the early dementia risk identification.

Methods

This study involved 196 older adults with normal cognition in a randomized controlled intervention trial. CFI was assessed every six months from baseline to 18 months, using the Alzheimer's Disease Cooperative Study-Preclinical Alzheimer Cognitive Composite (ADCS-PACC) to measure cognitive decline. We employed a mixed model for repeated measures to compare the CFI scores at 18 months in the ApoE4, ADCS-PACC, and allocation groups.

Results

CFI scores increased in ApoE4 carriers and decreased in the intervention group, with significant differences observed in the CFI score changes at 18 months between carriers and non-carriers and among the allocation groups (p = 0.002, p = 0.026, respectively). However, there was no significant difference in the CFI score change among ADCS-PACC groups (p = 0101).

Conclusions

We observed CFI scores worsening over time in individuals with ApoE4 and showing a tendency to deteriorate over time in those with objective cognitive decline. These findings suggest that the CFI may be able to identify high-risk individuals for dementia at an early stage. Furthermore, the improvement in the CFI score is considered a significant finding when considering future measures for subjective cognitive decline.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Apolipoprotein E4Cognitive DysfunctionDementiaHumansMaleFemaleAgedNeuropsychological TestsLongitudinal StudiesAged, 80 and overHeterozygoteMiddle AgedDisease ProgressionActivities of Daily Living

Stichwörter der Autor:innen

Alzheimer's diseaseapolipoprotein Edementiamild cognitive impairmentself reportsubjective cognitive decline

Substanzen

Apolipoprotein E4

Autor:innen und Institutionen

  • Department of Occupational Therapy, Faculty of Rehabilitation, Kobe Gakuin University, Ikawadani-cho, Nishi-ku, Kobe, Japan.
  • Department of Rehabilitation Science, Kobe University Graduate School of Health Sciences, Suma-ku, Kobe, Japan.
  • Department of Public Health, Kobe University Graduate School of Health Sciences, Suma-ku, Kobe, Japan.
  • Center for Physical Activity Research, National Institute of Health and Nutrition, National Institutes of Biomedical Innovation, Health and Nutrition, Settsu, Japan.
  • Department of Clinical Research Facilitation, Institute for Advancement of Clinical and Translational Science (iACT), Kyoto University Hospital, Shogoin, Sakyo-ku, Kyoto, Japan.

ORCID-Profile: Tohmi Osaki, Yutaro Oki, Ryoko Kumagai

Zitieren

APA

Osaki, T., Oki, Y., Kumagai, R., Ono, R., Yasuda, H., Nagai, Y., & Kowa, H. (2025). Longitudinal deterioration of subjective cognitive decline in apolipoprotein ε4 carriers and improvement of subjective cognitive decline by multi-domain intervention for prevention of dementia: The cognitive function instrument assessment. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877251332647

Vancouver

Osaki T, Oki Y, Kumagai R, Ono R, Yasuda H, Nagai Y, et al. Longitudinal deterioration of subjective cognitive decline in apolipoprotein ε4 carriers and improvement of subjective cognitive decline by multi-domain intervention for prevention of dementia: The cognitive function instrument assessment. Journal of Alzheimer’s Disease. 2025. doi:10.1177/13872877251332647

BibTeX
@article{Osaki2025,
  author = {Osaki, Tohmi and Oki, Yutaro and Kumagai, Ryoko and Ono, Rei and Yasuda, Hisafumi and Nagai, Yoji and Kowa, Hisatomo},
  title = {Longitudinal deterioration of subjective cognitive decline in apolipoprotein ε4 carriers and improvement of subjective cognitive decline by multi-domain intervention for prevention of dementia: The cognitive function instrument assessment},
  journal = {Journal of Alzheimer’s Disease},
  year = {2025},
  doi = {10.1177/13872877251332647}
}
Kostenlos starten →